Wedbush Securities Inc Vascular Biogenics Ltd. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$1.07 - $2.0 $58,315 - $109,000
-54,500 Closed
0 $0
Q3 2020

Oct 20, 2020
BUY
$1.11 - $1.4 $35,520 - $44,800
32,000 Added 142.22%
54,500 $66,000
Q2 2020

Jul 16, 2020
BUY
$1.12 - $1.63 $25,200 - $36,675
22,500 New
22,500 $29,000

Others Institutions Holding VBLT

# of Institutions
2
Shares Held
416K
Call Options Held
0
Put Options Held
0
View Full List

About Vascular Biogenics Ltd.

VBLT Quotes by TradingView
  • Ticker VBLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,348,896
  • Description
  • Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...
More about VBLT
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email